| 10.5.2022 | EN | Official Journal of the European Union | C 191/26 |
Judgment of the General Court of 2 March 2022 — VeriGraft v Eismea
(Case T-688/19) (1)
(Arbitration clause - Grant agreement concluded in the context of the ‘Horizon 2020’ Framework Programme for Research and Innovation - Termination of the agreement - Misconduct - Capacity as beneficiary of the grant or as a natural person acting in his or her name or on his or her behalf)
(2022/C 191/34)
Language of the case: English
Parties
Applicant: VeriGraft AB (Gothenburg, Sweden) (represented by: P. Hansson and A. Johansson, lawyers)
Defendant: European Innovation Council and SMEs Executive Agency (represented by: A. Galea, acting as Agent, and by D. Waelbroeck and A. Duron, lawyers)
Re:
Application based on Article 272 TFEU seeking a declaration of invalidity of the termination by the Executive Agency for Small and Medium-sized Enterprises (EASME) of the grant agreement concerning the project ‘Personalised Tissue Engineered Veins as the first Cure for Patients with Chronic Venous Insufficiency — P TEV’, concluded in the context of the instrument to support innovation in small and medium-sized enterprises of Horizon 2020 — the Framework Programme for Research and Innovation (2014-2020).
Operative part of the judgment
The Court:
| 1. | Declares that the termination by the Executive Agency for Small and Medium-sized Enterprises of the grant agreement for the project ‘Personalised Tissue Engineered Veins as the first Cure for Patients with Chronic Venous Insufficiency — P-TEV’, bearing reference 778620, is invalid; |
| 2. | Orders the European Innovation Council and SMEs Executive Agency to pay the costs. |
(1) OJ C 432, 23.12.2019.